Clinical trial
Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia
NCT00320723 · North Suffolk Mental Health Association, Other · Completed
Key facts
| NCT number | NCT00320723 |
|---|---|
| Title | Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia |
| Official title | Nicotine Replacement Therapy Added to Cognitive Behavioral Therapy for Smoking Cessation in Patients With Major Mental Illness |
| Lead sponsor | North Suffolk Mental Health Association, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | bupropion, transdermal nicotine patch |
| Enrollment | 100 |
| Start date | Jul 1, 2001 |
| Completion | Dec 1, 2005 |
| First posted | May 3, 2006 |
| Last update posted | May 19, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: